Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer

Stopped early · Phase 3

Conditions studied: Breast Cancer

In brief

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Toremifene may fight breast cancer by blocking the uptake of estrogen by the tumor cells. Atamestane may fight breast cancer by blocking the production of estrogen. It is not yet known if toremifene is more effective with or without atamestane. PURPOSE: Randomized phase III trial to compare the effectiveness of toremifene with or without atamestane in treating postmenopausal women who have metastatic breast cancer.

Key facts

Study ID

NCT00010322

Run by

Intarcia Therapeutics

Starts

2000-10-01

Expected to finish

2001-05-01

Last updated by the study team

2014-03-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Millennix Inc. — Purchase, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.